Compounds of formula 1 modulate the activity of Rho C: ##STR1##

wherein

    • R is a direct bond, lower alkylene, —C(O)NH—, or —NHC(O)—;
    • Ar is aryl or heteroaryl, substituted with R7, R8, R9, and R10, wherein R7, R8, and R9 are each independently H, halo, lower alkyl, OH, lower alkoxy, and R10 is H, halo, lower alkyl, OH, lower alkoxy, or forms a ring with R1;
    • R1 is H, lower alkyl, or forms a ring with R10;
    • R2, R3, R4, R5, and R6 are each independently H, lower alkyl, halo, nitro, OH, lower alkoxy, NH2, lower alkylamino, di(lower alkyl)amino, or two adjacent groups together form a saturated or unsaturated ring;
    • or a pharmaceutically acceptable salt thereof.
  •  
    Web www.patentalert.com

    < Selective inhibitors of the urokinase plasminogen activator

    < Imidazolyl-cyclic acetals

    > Heterocyclic compounds and uses thereof

    > Anti-inflammatory compounds and uses thereof

    ~ 00264